The process of liver colonization in colorectal cancer remains poorly characterized. Here, we addressed the role of microRNA (miRNA) dysregulation in metastasis. We first compared miRNA expression profiles between colorectal cancer cell lines with different metastatic properties and then identified target proteins of the dysregulated miRNAs to establish their functions and prognostic value. We found that 38 miRNAs were differentially expressed between highly metastatic (KM12SM/SW620) and poorly metastatic ( 
Introduction
Metastasis is a complex process involving multiple steps, including detachment of metastatic cells from the primary tumour, intravasation and survival in blood, and extravasation and colonization of distant organs [1] . We are interested in the role of microRNAs (miRNAs) in the process of metastasis by colorectal cancer cells. miRNAs are small (19-to 22-nucleotide) non-coding RNAs that can regulate fundamental aspects of tumourigenesis, either as oncogenes or as tumour suppressors [2] . miRNAs inhibit gene expression by multiple mechanisms, including transcript degradation, mRNA sequestering, and translational suppression [3] . Around 1880 miRNAs have been identified in humans, covering about 70% of the genome [4] .
Members of the miR-200 family were among the first miRNAs discovered to be involved in cell plasticity and metastasis in several cancers, including colorectal cancer [5, 6] . Various miRNAs have been related to colorectal cancer metastasis in different model systems [6] [7] [8] [9] [10] [11] [12] [13] [14] : miR-23a (mouse model), miR-34a-5p (p53-down-regulated tumours), miR-103/107 (various cell lines), miR-192 (TGFβ-treated colon cancer cells), miR-214 (tissue samples from metastatic patients), miR-493 (HCT116 cell line), and miR-483/miR-551 (metastatic cell lines). Using in silico procedures or transcriptomic profiling, different proteins have been assigned as targets of these miRNAs (miR-23a,
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miR-493: IGF1R [13] ; and miR-483/miR-551a: CKB and SLC6A8 [14] ).
Although miRNA targets are usually identified computationally by seed sequence conservation [15] , different algorithms predict hundreds of potential candidate targets in silico that have only limited overlap. This lack of correlation, as well as the lack of correlation between mRNA and protein levels, makes proteomic-based strategies a good alternative for identifying, quantifying, and validating miRNA-induced protein alterations in metastatic cells [16] [17] [18] [19] . Therefore, miRNA expression analysis followed by proteomic target identification could identify relevant effectors in colorectal cancer liver metastasis.
Comparing non-metastatic versus metastatic isogenic cell lines would offer a valuable insight into the molecular mechanisms involved in metastasis, as these cell lines differ mainly in miRNA and protein expression patterns. KM12C/KM12SM and SW480/SW620 are probably the best available models of isogenic cell lines differing in metastatic properties [20] [21] [22] . To our knowledge, no direct comparison of isogenic cell lines has been carried out to analyse differentially expressed miRNAs in colorectal cancer.
Here, we identified a large panel of differentially expressed miRNAs in metastatic cells and confirmed that three of them (miR-424-3p, miR-503, and miR-1292) were overexpressed in human cancer samples. Functionally, individual overexpression of the three miRNAs was sufficient for colon cancer cells to colonize the liver. A quantitative proteomic analysis of miRNA stably-transduced cells revealed an extensive overlap in the sets of altered proteins targeted by the three miRNAs. Specifically analysing CKB and UBA2 as target proteins of all three miRNAs revealed their role in cell proliferation and adhesion.
Materials and methods

Human samples
Tissue samples were obtained from the Surgical Pathology Departments of Fundación Jiménez Díaz and Hospital Clínico (Madrid) after approval of the Research Ethics Committee of the hospitals (see supplementary material, Supplementary materials and methods and Table S1 ).
Cell culture and transfections
KM12C and KM12SM human colon cancer cells were obtained directly from Dr Fidler's laboratory (MD Anderson Cancer Center, Houston, TX, USA). SW480 and SW620 cells were purchased from ATCC (Manassas, VA, USA). Cell lines were cultured in DMEM (Gibco-Thermo Fisher, Waltham, MA, USA) containing 10% fetal calf serum (FCS) and antibiotics at 37 ∘ C in a 5% CO 2 -humidified atmosphere. For transient transfections, KM12C cells were transfected with 50 nM mimic miR-424-3p, miR-503, miR-1292, or a negative control (Dharmacon, Lafayette, CO, USA); siRNAs targeting specifically CKB (SASI-Hs01-00194103; Sigma-Aldrich, St Louis, MO, USA), UBA2 (SASI-Hs01-00069072, Sigma-Aldrich); or control siRNAs using JetPrime (Polyplus, Illkirch, France). KM12SM cells were transfected with 50 nM antagomir miR-424-3p, miR-503, miR-1292, or a negative control (Dharmacon), and pCDNA3.1+, pCDNA3.1-CKB, or pCDNA3.1-UBA2 (GenScript, Piscataway, NJ, USA) using JetPrime. All experiments were performed 48 h after transfection.
miRNA analysis
Total RNA (1 μg) was extracted from KM12C or SW480 cells (poorly metastatic), or KM12SM or SW620 cells (highly metastatic) with the mirVana kit (Ambion-Thermo Fisher Scientific, Waltham, MA, USA) and used for miRNA expression profiling with TaqMan Megaplex human array A (v2.0) and B (v3.0) (Thermo Fisher). Total RNA was reverse-transcribed with the Multiplex real-time pool set (Thermo Fisher) and real-time products were subsequently amplified with sequence-specific primers on a 7900 HT Real-Time PCR system (Thermo Fisher). Reactions were incubated in a 384-well plate at 95 ∘ C for 10 min, followed by 40 cycles of 95 ∘ C for 15 s and 60 ∘ C for 1 min. Data were collected and processed using the Plate Utility and Automation Controller software (Thermo Fisher). U6 snRNA was used as a control. Results were analysed with the 'Expression suite software V1.01'.
Generation of lentivirus stably-transfected cells
pEZX-MR01 lentiviral vectors encoding for the selected miRNAs were purchased from GeneCopoeia (Rockville, MD, USA). Briefly, HEK293T cells were transfected with these vectors in combination with the packaging vectors pCMV-rev, pMDLg-pRRE, or pNGVL-VSVG using jetPRIME (Polyplus). Cells were incubated for 12-15 h in serum-free medium and then in fresh DMEM containing 10% FCS and antibiotics overnight. Lentiviral particles were then added to KM12C and KM12SM cells. After 3 days of incubation, infected cells were selected using 1 mg/ml puromycin (Sigma-Aldrich) for 2-3 weeks. Cells were then maintained in media containing 0.5 mg/ml puromycin. miRNA expression was tested by real-time PCR.
Cell adhesion and proliferation assays and colony formation in soft agar Cell adhesion and proliferation assays were carried out as previously described [23] . A bottom layer of 0.8% agarose in 10% serum DMEM was added to 6-cm plates. After solidification, a new agarose layer (0.67% in 10% serum DMEM) containing 1.5 × 10miRNAs in colorectal cancer metastasis 41 Quantitative PCR mRNAs were analysed with a SuperScript II First Strand Synthesis System using random hexamers (Invitrogen, Carlsbad, CA, USA) and real-time quantitative PCR (RT-qPCR) using the FastStart Master Mix (Roche, Barcelona, Spain) with probes from the Universal Probe Library Set (Roche). RNA was amplified with a LightCycler ® 480 (Roche). Each value was adjusted using 18S RNA levels as reference. For miRNA and mRNA analyses from patients, RNA from formalin-fixed, paraffin-embedded tissue was isolated from 3 × 10 μm sections using the NucleoSpin total-RNA FFPE XS kit (Macherey-Nagel, Duren, Germany). Levels of miR-424-3p, miR-503, miR-1292, and (as an endogenous control) U6 snRNA were analysed using a TaqMan microRNA assay (Thermo Fisher). miRNA expression was 'high' with tumour/normal ratios greater than or equal to 2; expression of the selected genes was 'low' with tumour/normal ratios less than or equal to 0.5.
Quantitative proteomic analysis
Mass spectrometry procedures and analyses were performed as previously described [24] (see supplementary material, Supplementary materials and methods).
In vivo animal experiments
All protocols for mouse experiments were approved by the Ethical Committee of the Consejo Superior de Investigaciones Científicas. KM12C and KM12SM (1.5 × 10 6 cells), either stably transfected (miRNAs) or transiently silenced (siRNAs), were intrasplenically injected into Swiss nude mice (Charles River, Wilmington, MA, USA) in 0.1 ml of phosphate-buffered saline. For metastasis experiments, mice were inspected daily for signs of disease, such as abdominal distension, locomotive deficit, or tumour detection by palpation. Once signs of illness were noted, or after 90 days, mice were euthanized and inspected for liver metastasis. For liver colonization, mice were inoculated with KM12 cells and euthanized 24 h after inoculation. Liver RNA was isolated using Trizol (Invitrogen) and retro-transcribed, and 0.3 μg of cDNA was used to amplify human GAPDH by PCR with Taq DNA polymerase (Invitrogen) [25] . Murine β-actin (Actb) was used as a control.
Validation with external cohorts and bioinformatic analysis
The GSE35834 dataset from GEO, which contains miRNA expression profiles from 45 patients with colorectal cancer (including 23 normal adjacent mucosae, 31 primary colorectal cancers, and 24 liver metastases), was used for bioinformatic analyses [26] . z-score values were calculated as previously described [27] .
To analyse miRNA binding sites, the 3'-UTR sequence for each selected gene was obtained using Genome Browser [28] . miRNA sequences were obtained from miRBase and potential binding sites were predicted with Segal Lab miRNA [29] . Prediction of miRNA targets was investigated with the miRWalk platform [30] .
Microarray raw data have been deposited in NCBI's Gene Expression Omnibus and are accessible through GEO Series accession number GSE86302 (https://www .ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE86302).
Statistical analysis
Analysis was carried out with one-way ANOVA followed by a Tukey-Kramer multiple comparison test for Gaussian continuous variables, and a chi-square test for discrete variables. Kruskal-Wallis and Fisher's tests were used for non-parametric statistics. Survival was analysed by the Kaplan-Meier method, and groups were compared with the log-rank test. Statistics were calculated and plotted using SPSS Statistics v22 (IBM).
Results
Differentially expressed miRNAs in metastatic cancer cell lines and colorectal cancer patients
Using TaqMan array microRNA cards (supplementary material, Figure S1 ), we identified 285 differentially expressed miRNAs (fold change ≥ 2) in KM12C/SM cells (75 up-regulated and 210 down-regulated) and 154 in SW480/620 cells (61 up-regulated and 93 down-regulated) (supplementary material, Table S2 ). Of the miRNAs that were altered in both cell lines, 38 dysregulated miRNAs (with 11 up-and 27 down-regulated) were selected for further analysis ( Figure 1A and supplementary material, Table S3 ). As confirmation of the value of the screening, 22 of these 38 had already been described for colorectal cancer.
To examine the expression of the identified miRNAs in primary tumours or liver metastases, we used the GSE35834 dataset of the miRNA expression profiles from 45 colorectal cancer patients. Five of the eleven up-regulated miRNAs (miRs-503, −29b-1-5p, −1292, −424-3p, and −1303) had increased levels in primary and metastatic tumours (supplementary material, Figure  S2 ). Up-regulated miRNAs were confirmed by qPCR for both cell lines, except for miR-1303 in KM12SM ( Figure 1B) . As miR-29b-1-5p was previously associated with colorectal carcinogenesis [31] , we focused on miR-503, miR-424-3p, and miR-1292.
Overexpression of miR-424-3p, miR-503, and miR-1292 promotes malignant traits and liver metastasis in mice in adhesion capacity and affected proliferation ( Figure 1C) . Moreover, experiments with antagomirs in metastatic KM12SM cells showed decreases in adhesion and proliferation ( Figure 1D ). For further assessment, miRNA-transduced KM12C cells showed a clear increase of the respective miRNA levels (miR-424-3p > 7-fold; miR-503 > 44-fold; and miR-1292 > 4.5-fold) with respect to control KM12C cells (supplementary material, Figure S3A ). The adhesion capacity of KM12C cells expressing miR-424-3p or miR-1292 increased 4-fold over control KM12C cells and was equivalent to that of the metastatic miR-C KM12SM cells (supplementary material, Figure S3B ). In contrast, miR-503 expression did not alter adhesion, probably due to differences in the endogenous processing machinery. Finally, KM12C cells expressing one of the three miRNAs showed an increased cell proliferation rate (supplementary material, Figure S3C ) as well as an increased capacity for colony formation ( Figure 1E ), compared with control KM12C cells, and similar to metastatic KM12SM cells. In contrast, no significant effects on cell migration or invasion were observed after expression of these miRNAs (data not shown).
Next, we investigated the capacity to generate liver metastasis in nude mice after intrasplenic inoculation with KM12C cells overexpressing miR-424-3p, miR-1292, miR-503, or a control miRNA. The three miRNAs, but not the control miRNA, led to an increase in liver metastases (Figure 2A ). The majority of mice developed metastatic nodules after inoculation with miR-503 (90%) and miR-1292 (78%), similar to KM12SM-induced metastasis (90%), and 60% also presented metastatic nodules after inoculation with miR-424-3p ( Figure 2B, C) . We also investigated the homing capacity for liver metastasis after intrasplenic injection -an assay that correlates well with the presence of metastatic nodules in the liver. At 24 h after inoculation, we noticed a significant increase in liver colonization by miRNA-expressing cells, as measured by detecting the human housekeeping gene GAPDH ( Figure 2D ). Survival of mice after miR-1292 or miR-503 inoculation was significantly shorter than that of KM12C-inoculated mice ( Figure 2E ). Collectively, these data confirmed that overexpressed miR-503 and miR-1292, and to a lesser extent miR-424-3p, confer highly metastatic properties to poorly metastatic KM12C cells.
Prognostic values in colorectal cancer
To determine their clinical value, we tested for the expression of miR-424-3p, miR-503, and miR-1292 in 144 paired samples from colorectal cancer patients with long-term follow-up using qPCR (supplementary material, Table S4 ). High expression levels (fold change ≥ 2) of miR-424-3p and miR-1292 were associated with shorter rates of disease-free and overall survival ( Figure 3A) . In contrast, miR-503 was not significantly associated with survival in human tumours. We next compared the expression of the three miRNAs in stage IV primary tumours with the corresponding liver metastases. We observed a significant increase of miR-424-3p and miR-503 in metastasis, but no significant differences for miR-1292 ( Figure 3B ). Together, these data suggest that miR-424-3p and miR-1292 are associated with metastasis and poor patient outcome. Figure S4A and Table  S5 ). miR-424-3p, miR-503, and miR-1292 showed similar alteration trends in the ratios of protein expression (supplementary material, Figure S4B , C). We found 149, 129, and 121 dysregulated proteins with a fold change ≥ 1.5 in KM12C cells overexpressing miR-424-3p, miR-503, and miR-1292, respectively (supplementary material, Table S6 ). Remarkably, many of the affected proteins were similar among the three miRNAs: 73% of the dysregulated proteins were identical between miR-424-3p and miR-503, and 67% between miR-503 and miR-1292 ( Figure 4A ). Moreover, 69, 64, and 56 dysregulated proteins were shared between metastatic KM12SM cells and miR-424-3p, miR-503, or miR-1292 KM12C cells, respectively (supplementary material, Table S7 ), and 41 proteins were shared between the cells containing the three miRNAs (supplementary material, Table S8 ). The top ten down-regulated proteins were almost identical between the three miRNAs ( Figure 4B ).
Target proteins of pro
Gene Ontology (GO) functional annotation of down-regulated proteins revealed major alterations in cytoskeleton organization and cell adhesion, migration, proliferation, and differentiation ( Figure 4C ). Furthermore, 33 out of the 34 down-regulated proteins common to the three miRNAs exhibited binding sites for each miRNA in their 3'-UTR mRNA sequences (supplementary material, Table S9 ). Using the miRWalk platform [30] , we analysed the percentage of proteins modulated by miRNAs that are predicted targets, based on the available mRNA transcript predictions for miR-503 (six different algorithms), miR-424-3p (three different algorithms), and miR-1292 (four different algorithms). We found a number of coincidences between the identified proteins and the predicted targets, with around 25% overlap between miR-503 and miR-424-3p, and 15% for miR-1292 (supplementary material, Table S10 ). Between 18 and 38 proteins were predicted in at least two lists with in silico methods (supplementary material, Table S11 ). Creatine kinase brain-type (CKB), the most dysregulated protein, was predicted by two independent algorithms. In contrast, many other proteins, such as ubiquitin-like modifier activating enzyme 2 (UBA2), , and the number of macroscopic metastases. P values were calculated using Fisher's test and Kruskal-Wallis, respectively (*p < 0.05; **p < 0.01; ***p < 0.001). (D) RNA from liver was isolated and subjected to RT-PCR to amplify human GAPDH. Murine β-actin was also amplified as a loading control. (E) Kaplan-Meier survival assay of nude mice inoculated with KM12 cells expressing the indicated miRNA. Differences between curves versus control transfected KM12C cells were determined using the log-rank test.
a protein involved in ubiquitination and sumoylation, were not predicted by any algorithm.
CKB and UBA2 are direct miRNA targets
Both CKB and UBA2 were expressed at lower levels in metastatic miRNA-expressing cells and SW620 cells than in non-metastatic KM12C and SW480 cells ( Figure 5A ). Consistently, CKB and UBA2 mRNAs decreased in miRNA-expressing KM12C cells and metastatic KM12SM cells ( Figure 5B ). Moreover, transient expression of miR-424-3p, miR-503, or miR-1292 in either cell system (SW/KM12) decreased CKB and UBA2 mRNA levels to those observed in metastatic cells (supplementary material, Figure S5 ). To investigate a direct interaction between the miRNAs and the 3'-UTR of CKB and UBA2 mRNAs, we assessed their capacity to regulate the expression of a luciferase reporter construct. Luciferase activity was reduced when cells containing psiCHECK-2 CKB UTR or psiCHECK-2 UBA2 UTR were co-transfected with the individual mimics, but not with the control mimic ( Figure 5C ). Moreover, combinations of two or three mimics did not further reduce luciferase activity, suggesting a lack of synergy between the three miRNAs ( Figure 5C ). We then investigated the contribution of CKB and UBA2 to the phenotype caused by the overexpression of the three miRNAs. Restoring CKB and UBA2 expression in KM12C control cells or cells transfected with one of the miRNAs led to a clear decrease of proliferation and, to a lesser extent, adhesion capacity ( Figure 5D ). Correspondingly, overexpression of CKB and UBA2 in metastatic KM12SM cells caused a decrease in adhesion and proliferation (supplementary material, Figure  S6 ). In contrast, transient siRNA-silencing of CKB and UBA2 in parental KM12C cells increased cell proliferation ( Figure 5E ), adhesion ( Figure 5F ), and homing ( Figure 5G ) for liver colonization in vivo, thereby recapitulating the effects of miR-424-3p, miR-503, and miR-1292 overexpression. Collectively, these data support the notion that CKB and UBA2 are direct targets of miR-424-3p, miR-503, and miR-1292, and that they play a role in proliferation and adhesion in colorectal cancer.
CKB and UBA2 are prognostic markers in colorectal cancer
In human samples, CKB expression was strong in normal colon tissue but was patchier and more variable in tumour tissue. CKB cytoplasmic staining occurred in 48% of primary tumours and 53% in metastatic tissues, with no nuclear staining. UBA2 showed nuclear expression in normal colon tissue and in 73% of primary tumours and 64% of liver metastases ( Figure 6A ). However, an estimation of the H-score in 273 samples of primary tumours and liver metastasis indicated that CKB and UBA2 expression intensity was similar ( Figure 6B ).
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To examine whether CKB and UBA2 have prognostic value, we analysed the expression in paired cancer/normal tissues using qPCR and immunohistochemistry. Using qPCR (n = 144), 96 patients showed low mRNA expression for CKB and 47 for UBA2 ( Figure 6C ). UBA2 was statistically significantly associated with overall survival (p = 0.009), while CKB was not (p = 0.424). Cumulative expression was significantly linked to survival. However, in immunohistochemistry miRNAs in colorectal cancer metastasis 49 analysis (n = 195), both CKB and UBA2 revealed an association with overall survival, with p = 0.028 and p = 0.016, respectively. The simultaneous expression of both was also highly significant (p = 0.001) ( Figure 6D ). In summary, low expression of CKB and UBA2 appears to be a suitable marker for poor prognosis and patient classification in colorectal cancer.
Discussion
Metastatic colonization requires primary cancer cells to adapt to growth in a different and harsh environment, such as the liver. This adaptation requires multiple changes in protein expression, which might be epigenetically regulated through the up-or down-regulation of multiple miRNAs. We observed a pro-metastatic role for miR-424-3p, miR-503, and miR-1292 in colorectal cancer progression and metastasis: (i) they increased proliferation, colony-formation, and adhesion properties; (ii) mice inoculated with KM12C cells expressing one of the three miRNAs showed a strong increase in liver metastasis and a shorter survival; and (iii) miR-424-3p and miR-1292 expression was significantly associated with a worse outcome in colorectal cancer patients. Additionally, quantitative proteomic analyses revealed an extensive overlap between the target proteins altered by miRNA overexpression. We validated CKB and UBA2 as direct targets of the three miRNAs. Low expression of CKB and UBA2 was also a prognostic marker of poor outcome in colorectal cancer. Previous studies in melanoma and colorectal cancer have reported a similar convergent effect of miRNAs on identical proteins using in silico or transcriptomic approaches [14, 32, 33] . However, as the three miRNAs in our study did not affect these two targets in an additive manner, we can consider that they represent alternative or complementary strategies to modulate metastatic colonization.
miR-424-3p and miR-503 form an miRNA cluster located in q26.3 of chromosome X. They belong to the mir-15/107 group, also known as the AGCx2 miRNAs cluster [34] , which has been implicated in mammary epithelium reorganization, apoptosis [35] , monocyte differentiation [36] , cell cycle arrest [36] , and angiogenesis [37] . miR-424 is up-regulated in hypoxia and stabilizes HIF-1α [37] , which is regulated by proline hydroxylation followed by ubiquitination and formation of the E3 ubiquitin ligase complex [38] . Even though miR-424-3p and miR-503 share a common genomic location, their biological effects in colon cancer metastasis were different: miR-503 had a more significant effect on mouse survival than miR-424-3p, while high expression of miR-424-3p, but not miR-503, was associated with poorer survival in human patients. Interestingly, whereas Noguchi et al [39] showed an association to relapse and poor prognosis in a high-expression group for miR-503 in colorectal cancer, the results from Li et al [33] were similar to ours: survival analysis based on miR-503 alone did not correlate with outcome, and only a combination with other miRNAs demonstrated prognostic value. Finally, miR-1292, which is located on chromosome 20p13 and was first identified in human embryonic stem cells [40] , has not been previously implicated in cancer.
Unexpectedly, our proteomic approach revealed similar programmes of protein alterations for the three miRNAs, with almost identical top ten down-regulated proteins. These experimental results differed from in silico predictions. Target analysis with the miRWalk platform revealed only minimal overlap between the different targets predicted for the three miRNAs and those quantified by proteomics. Likewise, our proteomic approach did not detect previously published in silico targets for miR-424/503, such as IGF1R, BCL2, CCNE1, and FBXW7 [33, 35, 36] . In contrast, while CKB was among the predicted targets, many identified proteins were not predicted by any algorithm, such as UBA2. Thus, in addition to bioinformatic prediction algorithms, complementary methods such as proteomic approaches should be used to identify functionally contributing targets.
UBA2 demonstrated interesting properties as a metastasis suppressor. UBA2 forms a heterodimer with SAE1, which functions as a SUMO-activating enzyme [41] and was also down-regulated in our proteomic analysis. FBXW7, which has been reported as a direct target of miR-27a in colorectal cancer progression [12] , is an F-box protein related to the ubiquitin protein ligase complex within the SKP1-CUL1-F-BOX protein network [42] . This complex has been associated with miR-424 and partially overlaps with the activity of UBA2. Inactivation of UBA2 leads to mitotic catastrophe and cell death upon Myc hyperactivation in human mammary epithelial cells [43] . As Myc activation is also common in colorectal cancer [44] , further experiments will be necessary to clarify the role of UBA2 in colorectal cancer.
The most dysregulated protein by the three pro-metastatic miRNAs was CKB, which reversibly catalyses phosphate transfer between ATP and creatine phosphate and plays a central role in energy supply in tissues with large demand [45] . This enzyme is overexpressed in many cancers, with the exception of colorectal cancer [46, 47] and metastatic prostatic cancer [48] , where it is progressively down-regulated. Our results support down-regulation of CKB as a major effect of the three pro-metastatic miRNAs, implying a suppressor role for intracellular CKB in metastasis. Immunohistochemical analysis showed that almost 50% of liver metastases were negative for CKB expression. However, Loo et al recently reported CKB as a target for two metastasis suppressor miRNAs (miR-483 and miR-551a) in colorectal cancer [14] . This finding apparently contradicts both our observations that CKB is significantly down-regulated (at the mRNA and protein levels) in highly metastatic colorectal cancer cells, and the reported down-regulation of CKB in colorectal50 S Torres et al in colorectal cancer metastasis remains an intriguing question. Metastasis is clearly not dependent on a unique factor and although a tumour with low expression of CKB and UBA2 has gained more metastatic potential, many other factors are certainly required to develop a complete metastatic programme.
In summary, we have defined a panel of at least three miRNAs and two target proteins that constitute relevant candidates for therapeutic intervention in liver metastasis. The three pro-metastatic miRNAs targeted a common panel of proteins, suggesting a convergent and/or complementary mechanism of action that is, however, not cooperative. Functional and survival analyses revealed a role for CKB and UBA2 in proliferation, adhesion, and homing. Thus, the action of multiple miRNAs on the same set of proteins might be necessary for a more efficient regulation of the metastatic process. This convergent action also points out the necessity of targeting multiple miRNAs rather than single miRNAs for a more efficient therapeutic strategy. Figure S1 . Screening for differentially expressed miRNAs in metastatic colon cancer cells Figure S2 . Expression of the selected miRNAs in normal adjacent mucosa, primary colorectal cancer, and liver metastases Table S2 . Quantified miRNAS in highly metastatic (KM12SM and SW620) versus poorly metastatic (KM12C and SW480) colorectal cancer cell lines Table S3 . Dysregulated miRNAs shared between highly and poorly metastatic cell lines Table S4 . Relationship between clinicopathological parameters and miRNA expression in patients with colorectal carcinoma, as analysed by qPCR Table S5 . Global list of proteins identified and quantified in cellular extracts of transfectant KM12 cells overexpressing one of the three miRNAs Table S6 . List of proteins differentially expressed in the whole cellular extract of miRNAs overexpressing KM12C cells with fold change ≥ 1. 5   Table S7 . Deregulated proteins in both KM12C cells overexpressing miRNAs and KM12SM cells Table S8 . Altered proteins shared between miR-424-3p, miR-503, and miR-1292 cells and metastatic KM12SM cells Table S9 . Binding sites predicted for each miRNA in the 3'-UTR of the down-regulated proteins 
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